Introduction The global rise in early-onset gastrointestinal malignancies has become a major oncologic concern, with pancreatic ductal adenocarcinoma (PDAC) increasingly being diagnosed in patients younger than 50 years. Although younger patients are generally presumed to tolerate aggressive multimodality treatment better, the biological behavior of early-onset pancreatic cancer (EOPC) remains poorly understood.
Introduction
The global rise in early-onset gastrointestinal malignancies has become a major oncologic concern, with pancreatic ductal adenocarcinoma (PDAC) increasingly being diagnosed in patients younger than 50 years. Although younger patients are generally presumed to tolerate aggressive multimodality treatment better, the biological behavior of early-onset pancreatic cancer (EOPC) remains poorly understood.
Problem Statement
Existing studies evaluating outcomes in EOPC have produced conflicting results, and the molecular mechanisms underlying disease aggressiveness in younger patients remain unclear. Whether EOPC differs biologically from late-onset PDAC has important implications for prognosis, surveillance and therapeutic decision-making.
Summary
This large multicenter translational study demonstrated that surgically resected EOPC is associated with significantly earlier postoperative recurrence and more aggressive molecular characteristics compared with late-onset PDAC. Despite receiving adjuvant chemotherapy more frequently and completing treatment more often than older patients, individuals with EOPC experienced shorter disease-free survival and remained at increased risk of recurrence after resection. Importantly, these poorer outcomes could not be explained by conventional clinicopathological factors such as tumor stage, nodal burden, margin status or differentiation grade. Transcriptomic analysis revealed enrichment of squamous (basal-like) molecular subtype signatures in EOPC, including increased expression of aggressive genes such as S100A2, TP63 and MYC-related proliferative pathways, alongside downregulation of GATA6, a marker associated with the more favorable classical pancreatic subtype. Gene programs linked to cell proliferation, squamous differentiation, inflammation and metabolic reprogramming were significantly enriched in younger patients, supporting a biologically aggressive phenotype. Additionally, immune-related gene pathways appeared relatively suppressed in EOPC, although major differences in immune cell infiltration were not definitively demonstrated. Germline mutations were not more common in younger patients, suggesting that inherited predisposition alone does not explain disease biology. Collectively, the findings challenge the assumption that younger age predicts favorable pancreatic cancer outcomes and instead support EOPC as a distinct high-risk biological subtype that may require intensified surveillance, earlier systemic therapy optimization and prioritization for biomarker-driven clinical trials.
Introduction: Chronic postoperative inguinal pain (CPIP) remains one of the most important long-term complications after laparoscopic groin hernia repair, despite lower rates than with open surgery. Whether different mesh types and fixation methods influence the...
Introduction: Venous involvement is common in locally advanced pancreatic cancer and often necessitates superior mesenteric-portal vein resection with reconstruction during pancreaticoduodenectomy. However, reconstruction may not always be feasible because of extensive venous disease or unfavorable...
Introduction: Pancreatoduodenectomy remains one of the most complex abdominal operations. Robotic pancreatoduodenectomy (RPD) has been proposed to improve postoperative recovery, but robust randomized evidence has been limited. The PORTAL trial compared robotic and open pancreatoduodenectomy...
Introduction: Surgery is an inherently high-stress profession, where complications, patient deaths, and difficult decisions can lead to burnout, moral injury, and mental health disorders. Inspired by the US Marine Corps' Combat and Operational Stress Control...
Introduction: As surgical techniques and perioperative therapies have advanced, vascular resection during pancreatic cancer surgery has become increasingly common in selected patients with locally advanced disease. This study evaluated the long-term outcomes of venous and...
Introduction: Optimal drain management after pancreatoduodenectomy (PD) remains critical for preventing postoperative pancreatic fistula (POPF) while supporting enhanced recovery. This study proposes a dynamic, risk-adapted algorithm based on intraoperative risk and postoperative biochemical markers. Why...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.